Loading...
Loading...
St. Jude Medical, Inc.
STJ today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare and the launch of the Trifecta™ aortic stented, pericardial tissue valve. The first procedures in Japan were performed at Osaka University Hospital and Saitama Medical University International Medical Center.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in